Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-24

Clinical Trial Update: Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating precision medicine approaches combining radioembolization with biological therapy for unresectable intrahepatic cholangiocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Francesco De Cobelli | Conditions: Intrahepatic Cholangiocarcinoma | Phase 2 | Status: RECRUITING